It's possible to have symptoms of Lambert-Eaton syndrome up to 6 years before SCLC is discovered. Muscle weakness could be the tip-off that leads your doctor to a lung cancer diagnosis.

This attack affects how nerve cells communicate with muscle cells, leading to symptoms of weakness and fatigue in the affected muscles. LEMS, also known as Lambert-Eaton syndrome (LES), is a rare ...

Myasthenia gravis and Lambert-Eaton syndrome both cause unusual muscle weakness but in different ways. In addition to slight differences in symptoms, they produce different diagnostic test results ...

Treating the underlying cause may significantly improve LEMS symptoms. A doctor may also recommend medications, such as: Some factors may improve or worsen MG. An infection, fever, or reaction to ...

Catalyst Pharmaceuticals has submitted a New Drug Application (NDA) for Firdapse (amifampridine) for the symptomatic treatment of Lambert-Eaton myasthenic syndrome (LEMS). The NDA is supported by ...

Patients with nontumor Lambert-Eaton myasthenic syndrome had survival rates comparable ... “Limited data suggest some improvement of symptoms in patients with LEMS with SCLC after treatment ...

May 6, 2019 /PRNewswire/ -- The U.S. Food and Drug Administration today approved Ruzurgi (amifampridine) tablets for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) in patients 6 to less ...

The FDA has approved amifampridine tablets for the treatment of adult patients with Lambert-Eaton myasthenic syndrome, according to a press release. Characterized by autonomic changes, depressed ...

The FDA has granted approval to the first treatment for children with Lambert-Eaton myasthenic syndrome (LEMS), a ... causing weakness and other symptoms, and causing the immune system to attack ...